Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximab.
Dourthe ME, Auperin A, Rigaud C, Barbati M, Bonneau J, Buchbinder N, Couec ML, Dartigues P, Ducassou S, Garnier N, Haouy S, Jonca B, Jourdain A, Leruste A, Molina T, Montravers F, Pasquet M, Phulpin A, Poirée M, Simonin M, Spiegel A, Verschuur A, Leblanc T, Landman-Parker J, Patte C, Minard-Colin V. Dourthe ME, et al. Among authors: simonin m. Haematologica. 2024 Nov 1;109(11):3790-3794. doi: 10.3324/haematol.2024.285403. Haematologica. 2024. PMID: 38988265 Free PMC article. No abstract available.
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.
Alcantara M, Simonin M, Lhermitte L, Touzart A, Dourthe ME, Latiri M, Grardel N, Cayuela JM, Chalandon Y, Graux C, Dombret H, Ifrah N, Petit A, Macintyre E, Baruchel A, Boissel N, Asnafi V. Alcantara M, et al. Among authors: simonin m. Blood Adv. 2019 Jul 9;3(13):1981-1988. doi: 10.1182/bloodadvances.2018028993. Blood Adv. 2019. PMID: 31270080 Free PMC article.
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Dourthe ME, Phulpin A, Auperin A, Bosq J, Couec ML, Dartigues P, Ducassou S, Garnier N, Haouy S, Leblanc T, Leruste A, Paillard C, Rigaud C, Simonin M, Patte C, Minard-Colin V. Dourthe ME, et al. Among authors: simonin m. Haematologica. 2022 Sep 1;107(9):2173-2182. doi: 10.3324/haematol.2021.280257. Haematologica. 2022. PMID: 35236054 Free PMC article.
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
Rigaud C, Abbou S, Ducassou S, Simonin M, Le Mouel L, Pereira V, Gourdon S, Lambilliotte A, Geoerger B, Minard-Colin V, Brugieres L. Rigaud C, et al. Among authors: simonin m. Haematologica. 2022 Sep 1;107(9):2255-2260. doi: 10.3324/haematol.2021.280081. Haematologica. 2022. PMID: 35586965 Free PMC article. No abstract available.
The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia.
Dourthe ME, Andrieu GP, Potier A, Balducci E, Guerder J, Simonin M, Courtois L, Petit A, Macintyre E, Boissel N, Baruchel A, Asnafi V. Dourthe ME, et al. Among authors: simonin m. Haematologica. 2023 Nov 1;108(11):3165-3169. doi: 10.3324/haematol.2022.282605. Haematologica. 2023. PMID: 36891734 Free PMC article. No abstract available.
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL.
Dourthe ME, Courtois L, Andrieu GP, Simonin M, Touzart A, Lhermitte L, Petit A, Boissel N, Baruchel A, Asnafi V, Macintyre E. Dourthe ME, et al. Among authors: simonin m. Hemasphere. 2023 Mar 17;7(4):e871. doi: 10.1097/HS9.0000000000000871. eCollection 2023 Apr. Hemasphere. 2023. PMID: 36950021 Free PMC article. No abstract available.
114 results